Strengthening Families & Communities LLC Sells 3,773 Shares of Danaher Co. (NYSE:DHR)

Strengthening Families & Communities LLC reduced its stake in Danaher Co. (NYSE:DHR) by 96.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 140 shares of the conglomerate’s stock after selling 3,773 shares during the quarter. Strengthening Families & Communities LLC’s holdings in Danaher were worth $32,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in DHR. First Fiduciary Investment Counsel Inc. lifted its position in Danaher by 1.8% during the 4th quarter. First Fiduciary Investment Counsel Inc. now owns 42,796 shares of the conglomerate’s stock worth $9,824,000 after buying an additional 741 shares in the last quarter. Pineridge Advisors LLC lifted its position in Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after buying an additional 57 shares in the last quarter. Quilter Plc lifted its position in Danaher by 4.6% during the 4th quarter. Quilter Plc now owns 62,371 shares of the conglomerate’s stock worth $14,317,000 after buying an additional 2,746 shares in the last quarter. Elevate Capital Advisors LLC bought a new stake in Danaher during the 4th quarter worth about $829,000. Finally, Angeles Wealth Management LLC lifted its position in Danaher by 5.1% during the 4th quarter. Angeles Wealth Management LLC now owns 4,229 shares of the conglomerate’s stock worth $971,000 after buying an additional 204 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Insider Transactions at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 11.10% of the stock is currently owned by insiders.

Danaher Stock Performance

Shares of NYSE:DHR opened at $203.42 on Tuesday. The company’s 50 day moving average price is $232.72 and its two-hundred day moving average price is $251.61. Danaher Co. has a 12-month low of $203.00 and a 12-month high of $281.70. The firm has a market cap of $146.92 billion, a PE ratio of 38.53, a PEG ratio of 2.68 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the firm posted $2.09 EPS. Equities research analysts predict that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.53%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s dividend payout ratio (DPR) is presently 20.45%.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Royal Bank of Canada reissued an “outperform” rating and set a $277.00 price target (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Robert W. Baird dropped their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Raymond James reaffirmed a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Finally, Stephens reaffirmed an “overweight” rating and issued a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. Seven analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.